About Michael Grissinger
Form D filings for NephroDI Therapeutics in 2024 list Michael Grissinger as director.
Michael Grissinger first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Grissinger in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Grissinger works with at each company, as listed on that company's latest Form D.
NephroDI Therapeutics, Inc. · Form D, Jun 18, 2024
RH
Rachael Hagan
President and director
BM
Bibhash Mukhopadhyay
Director
JD
Jeff Sands, M.D.
Executive officer